Co-Founder and Chief Executive Officer of OWKIN, a French- American TechBio using foundational models in biology and access to the largest federated patients data network to bring first-in-class artificial intelligence (AI)-powered diagnostics and molecules every year to patients. Leads medical research and business intelligence. Former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris and former Member of the Ari Melnick lab at the Weill Cornell Medical College. Ensures that patient health is prioritized when developing breakthrough medical technologies, bringing a patient- centric approach to each Owkin project.
